Michigan Fines MuhaMeds Manufacturer
Michigan’s Regulatory Agency ordered Michigan Investments 10, the licensed manufacturer behind Muha Meds products in the state, to cease operations September 24th and pay a $2 million penalty—the largest fine Michigan has imposed on a licensed operator.
Regulators cited repeated problems including inadequate testing, surveillance failures and serious discrepancies in Metrc; during one inspection, the company reportedly could not physically locate 16 packages representing 105.7 pounds of product, while investigators also found distillate packages without Metrc tags.
This case actually began in 2023. The CRA suspended the processor that November after finding large quantities of improperly tracked or untraceable material, missing tags and testing irregularities; the agency said some finished products had passed compliance testing but could not be traced back to regulated source flower or concentrate.
An administrative law judge later allowed operations to resume, but in June 2026 a judge upheld evidence supporting 31 violations, setting up this week’s final enforcement action.
The interesting part isn’t the $2 million headline. It’s that traceability itself became evidence of potential inversion or diversion. A finished product can have a passing test result and still fail the regulatory chain if the system cannot demonstrate where the material came from, where it went and whether the physical inventory matches the electronic record.
